Novozymes Biopharma to present latest advances in cell culture technology at ESACT
12 April 2011 | By The Scott Partnership
Novozymes Biopharma, will present two scientific posters at the 2011 ESACT meeting...
List view / Grid view
12 April 2011 | By The Scott Partnership
Novozymes Biopharma, will present two scientific posters at the 2011 ESACT meeting...
12 April 2011 | By kdm communications limited
Sigma Life Science, today announced the signing of an agreement with KBLB...
12 April 2011 | By Project PR
Dr. Reddy’s Laboratories has announced the opening of its newly expanded Chirotech Technology Centre...
12 April 2011 | By kdm communications limited
Leica Microsystems has announced the European release of the fully automated Leica HER2 FISH System...
11 April 2011 | By Lukats Shapiro Communications
APEL has announced the appointment of Ken Jones as its President and CEO...
11 April 2011 | By GDS International
Every other industry is getting on the social media bandwagon. But could social media actually prove beneficial to the world of pharma?...
Lonza (SIX Swiss Exchange: LONN) and Roche (SWX: ROG) announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche’s MycoTOOL® mycoplasma Polymerase Chain Reaction (PCR) assays.
11 April 2011 | By The Scott Partnership
ITT Corporation announces the first of the ebro EBI 40 multi-channel data loggers...
11 April 2011 | By Merck
After a pre-specified interim analysis the DMC has recommended suspension of enrollment...
11 April 2011 | By Citigate Dewe Rogerson Ltd
immatics, announced that Pfizer are to support its pivotal Phase III trial (IMPRINT) with IMA901...
8 April 2011 | By Sanofi-Aventis
Sanofi-aventis has announced that it has completed its acquisition of Genzyme Corporation...
8 April 2011 | By Amgen
Amgen announced today the expansion of its operations in Brazil, including the acquisition of Bergamo...
8 April 2011 | By Johnson & Johnson
Johnson & Johnson announced today it will pay $70,006,316 in fines...
8 April 2011 | By Novartis
Novartis shareholders followed the Board of Directors' recommendation, approving the proposed merger of Alcon, Inc. into Novartis...
7 April 2011 | By AstraZeneca
AstraZeneca today announced that the FDA approved the orphan drug vandetanib for the treatment of medullary thyroid cancer...